Results The 5-year OS rate of the entire sample was 44.3%(95% confidence interval: 36.7–
55.8); Child–Pugh class B was the worst negative prognostic factor (hazard ratio: 2.06; P …

Objective To compare the long-term efficacy of microwave ablation (MWA) for subcapsular
and non-subcapsular hepatocellular carcinomas (HCCs) using propensity score matching …

Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …

Current guidelines advocate percutaneous radiofrequency (RF) ablation as a standard
treatment of early stage hepatocellular carcinoma (HCC) for up to three tumors≤ 3 cm in …

OBJECTIVE: This study evaluated the safety and efficacy of using radiofrequency ablation
combined with transarterial chemoembolization to treat hepatocellular carcinoma in a …

We evaluated the efficacy and safety of radiofrequency (RF) ablation for hepatocellular
carcinoma (HCC) in presumably high‐risk locations. Between February 1999 and December …

Radiofrequency ablation (RFA) is recommended as a first-line therapy for small
hepatocellular carcinoma (HCC). Tumor location is a potential factor influencing the …

Abstract Background and Aim We compared the clinical outcomes of radiofrequency
ablation (RFA) and stereotactic body radiation therapy (SBRT) in small (≤ 3 cm) …

Objectives Radiofrequency ablation (RFA) of medium-sized (3–5 cm) hepatocellular
carcinoma (HCC) is suboptimal. Switching monopolar RFA (SW-RFA) enlarges the ablative …

Purpose To compare radiofrequency (RF) ablation with nonanatomic resection (NAR) as first-
line treatment in patients with a single Barcelona Clinic Liver Cancer (BCLC) stage 0 or A …